Daily news email for March 15, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Ceva Takes Commercial License for ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production

UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target

Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

Haselmeier Establishes New Pen Injector Assembly Facility in India

BioSpace
Tranzyme Pharma and Norgine Bowel Drug Fails Trial

Anthera Pharmaceuticals, Inc. Tanks as it Halts Phase III VISTA-16 Heart Drug Trial

Tranzyme Pharma and Norgine Bowel Drug Fails Trial, Shares Crash -2.18(42.75%) @ 1:08PM EDT

Anthera Pharmaceuticals, Inc. Tanks as it Halts Phase III VISTA-16 Heart Drug Trial; Stock Falls -2.99(46.57%) @ 1:09PM EDT

New Approach to Treating Type 1 Diabetes Transforming Gut Cells Into Insulin Factories, Columbia University Study

BioSpace - Breaking News
United Therapeutics Corporation Files Lawsuit Against Sandoz, Inc. for Infringement of Remodulin Patents

Shire plc Provides Update on US Biologics License Application Filing for REPLAGAL(R) (agalsidase alfa)

South Korea to Approve Pfizer Inc.'s Viagra Generics

Apotex Inc. Drug Maker Sues U.S. for $520 Million Under

Fitzsimons Redevelopment Authority Names New President & CEO

Biotech News - Business Wire
SORIN GROUP : RISULTATI DEFINITIVI 2011 CONFERMANO I DATI PRELIMINARI COMUNICATI IN DATA 9 FEBBRAIO 2012

Sorin Group : Final Results for 2011 Confirm Preliminary Figures Published on February 9, 2012

iCAD Launches Post-Market Study of Intra-Operative Radiation Therapy to Treat Early Stage Breast Cancer

RBCC Closes Deal with Game Changing Biotech Firm

Resumen: DIA Europe se asocia con una nueva academia de pacientes

Biotech News - PR Newswire
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery

Sigma-Aldrich Corporation Will Hold Its Business Review March 29, 2012

Innovation Day 2012 - International Convention on Primary and Administration Packaging Systems for Biotech Pharmaceuticals

AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board

Boston Scientific Announces Health Canada Approval of Blazer Open-Irrigated Catheter

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
The Single Biggest Opportunity to Improve Health Outcomes

Gilead Falls on News of Additional Hep C Patients Relapsing

Hospital Quality Reporting Program Had Little Impact on Death Rates

Cost of Drugs Rockets Past Inflation, Says AARP

J&J Impresses with Prostate Cancer Drug

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Chan Soon-Shiong Musculo-Skeletal Science Center at Saint John's Announced at Corporate Leadership Event Honoring Tim Leiweke

Research and Markets: Crohn's Disease Global Clinical Trials Review, H1, 2012

Research Demonstrates Moisturizing Formula with Niacinamide is Key in Providing Rapid, Lasting Dry Skin Benefits over Conventional Moisturizers

Study Indicates Guided Therapeutics LuViva® Advanced Cervical Scan Could be used as an Initial Screen for Cervical Cancer

Research and Markets: HIV-1 infection Global Clinical Trials Review, H1, 2012

Clinical Trials - PR Newswire
Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes

New Study Shows the Positive Effect of Low-Carb Diets, Like the Atkins Diet, Versus Low-Fat Diets on Weight Loss and Vascular Health

Groundbreaking, Long-Term Study of Head Injuries Among Athletes Kicks Off With NCAA Grant

American Association of Critical-Care Nurses Awards $50,000 Impact Research Grant to Boston Pediatric Nurse Researcher

PLC Announces Ministry of Health Approval to Distribute RenalGuard® in Israel Through A.M.I. Technologies, Ltd.

CNN Top Stories
Activist: Syria toll near 10,000

Child found living among corpses

Afghan president calls for U.S. troop pullback

Protesters want Afghan trial in killings

Taliban suspend talks with U.S.

Contract Pharma
Aptuit Appoints COO

Temporary Content Title

Biogen Idec, MAKScientific In MS Pact

Shire To Acquire FerroKin BioSciences

Unigene Labs Adds CFO

FDA Drugs- What's New
Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA News - Business Wire
Simpirica Spine Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex Spinal Stabilization System

BioCardia and Juventas Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure

A EffRx Anuncia: A FDA aprova BINOSTO®, Primeiro e Único Tratamento de Osteoporose Efervescente em uma Solução Tamponada

EffRx annonce : La FDA approuve BINOSTO®, le premier et le seul traitement effervescent contre l'ostéoporose sous forme de solution tamponnée

SANUWAVE Reports 2011 Financial Results and Provides Update on dermaPACE FDA Status

FDA Press Releases
FDA approves first generic Lexapro to treat depression and anxiety disorder

La FDA aprueba nuevos implantes de seno rellenos de gel de silicona

FDA approves new silicone gel-filled breast implant

FDA approves first cell-based product to treat oral mucogingival conditions in adults

FDA Commissioner Margaret A. Hamburg's Statement on the Surgeon General's Report

FDA Vaccines, Blood and Biologics - What's New
Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

FierceBiotech
Biogen Idec strikes $34M option pact with MAKScientific

UPDATED: Merck offers $90M to bankroll new drug discovery institute

Sofinnova preps Irish venture plans with $37.5M in fresh support

Merck offers $90M to bankroll new drug discovery institute

Did Big Pharma scuttle an attempt to radically restructure the approval pathway

FierceBiotech IT
Stanford algorithm uncovers drug side effects

Biomatters taps Ammundsen as CEO

Medidata projects big year, settles lawsuit

Accelrys stays on growth track in Q4

Google VC-backed startup plays 'Moneyball' in Big Pharma partnerships

FierceBiotech Research
Protein hampers bladder cancer metastasis

Beefed-up aspirin, charged with gas, conquers colon cancer in lab

RhoGDI2 protein hampers bladder cancer metastasis

Glaucoma-stricken rats see better, thanks to stem cells

U.K. research knocks wind out of personalized medicine push

FiercePharma
Forest mourns as Teva celebrates launch of generic Lexapro

GSK offloads consumer brands to Omega, delays Alli sale

J&J's Weldon due for $143M retirement package

Chinese officials intent on 'Anhui model' for price cuts

UPDATED:Pfizer's marketing pact with Biocon falls apart

FiercePharma Manufacturing
Pfizer CEO: More than 50 fakes of our drugs discovered last year

Omega gets German plant as part of OTC deal with GSK

Pfizer's new U.K. cold storage facility has hot new vaccines line

J&J's Weldon to get $143M in retirement

Sanofi cuts continue with closing of manufacturing plant in U.K.

FierceVaccines
World has huge unmet vaccine needs

In the clinic, Inovio's HIV vaccine treats as well as prevents

Hep C vaccine heads into further clinical trials

GeoVax steps closer to HIV prevention

MUC1 cancer vaccine starts in the clinic

Health News - BizJournals.com
Tom Fogarty's Emergent Medical fund raises millions

Kansas City area gets one seat on Brownback's Medicaid reform panel

Omega to pay GSK $614M to market Glaxo's OTC drugs

WPAHS: Key jobs getting filled

U.S. HealthWorks acquires center at Florida Hospital

Health News - CNBC
GSK sells consumer brands in Europe for $614 mln

Chinese Insurers Are a Long Term Risk: Analyst

Ad campaign shows smoking's scary side

Larry's Lessons & the GOP Race

Movers roundup: Apple, Rite Aid

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Report Cautions More Drugs, Diagnostics Needed in Europe for Multiple Sclerosis

$6.2M Investment in Mucosal Drug Firm Kala Completes $11.2M Seed Financing

Nearly Half the Respondents to a Recent GEN Poll Foresee No Job Cuts Where They Work

India Orders First Compulsory License for Bayer's Nexavar Cancer Drug to Natco

Recent Poll Results Highlight How Divisive Gene Patenting Is

Marketwire - Pharma and Biotech
Arch Awarded Funding from the Government of Canada to Develop Brain Tumour Targeting Technology

Allezoe (ALZM) Announces New Management for SureScreen Medical

Purdue Innovation Fund Awards Nearly $500,000 for Research in Diabetes, Concussions, Cancer and 7 Other Projects

Merus Labs International Inc. Announces First Quarter Results for Fiscal 2012

marPhase III Study of Teva's Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients

MassBio News
Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

MassBio's Peter Abair discusses growth in the cluster with US Building Digest

Medical Pharma - PR Newswire
Cogmedix Provides Medical Device Storage and Order Fulfillment Services for Telcare Medical Supply

Increasing HCAHPS Scores: What Healthcare HR Should Focus On

AUA Foundation Announces Renewal of the Astellas Rising Stars in Urology Award Program

Breathe Easily, Sleep Well: World Sleep Day Promotes Healthy, Undisturbed Sleep on March 16, 2012

The Patient's Guide & Cynosure, Inc. Partner to Launch Nail Fungus Authority Website, Nail-Fungus.com

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
India Orders Bayer to License Patented Cancer Drug

New Worries About Sleeping Pills

India Overrules Bayer, Allowing Generic Drug

Trial Shows Benefit in Earlier Use of Zytiga

Setback on AIDS Pill Is Re-Evaluated

OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

Outsourcing-Pharma
Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Pharma News - Business Wire
Completed Clinical Trial Further Indicates Cell-in-a-Box® Encapsulation Technology Has the Potential to Treat a Wide Array of Solid Tumors

Research and Markets: Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics: Pipeline Assessment and Market Forecasts to 2019

IntelliCell Announces article by Ray Dirks of RAY DIRKS Research published on CPReports.com

Samenvatting: Gedeon Richter Spain gebruikt Mobile Intelligence; het CRM-systeem van Cegedim Relationship Managements

Pharmaceutical Business Development Groups Adapt to More Complex Strategic Demands

Pharma News - PharmiWeb
SIPP International Industries, Inc. Completes $2.8 Million Secured Financing

Parkinson's Disease Foundation Welcomes 25 Research Advocates from Southern Region Working to Speed New Treatments for Parkinson's

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Specialty Urological Products

CEO Angel Stanz of BG Medical Technologies Talks to "The Stock Radio" About the Medical Marijuana Industry, Natural Medicine Technology, and 2012 Goals

Simon Lance appointed Regional Director of Hays in China

Pharma News - PR Newswire
ChromaDex® Announces Financial Results for the Year Ended 2011

Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA)

Novelos Therapeutics Announces Enrollment of First Patient in Brain Cancer Trial with I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center

Amgen Announces 2012 Second Quarter Dividend

United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Genomind Announces New Enhancements to Leadership Team

Lnx Pharma Announces New Method to Identify Disease Area Opinion...

Judea Pearl Wins ACM Turing Award For Contributions that Transformed...

DuPont Wins 2012 Sustainable Biofuels Award for Feedstock Innovation

Sentara Heart Hospital Discharges 1st Total Artificial Heart Patient...

PRWeb - Pharmaceuticals
Pfizer Animal Health Continues to Invest in the Future of...

New CPAP Machines That Hit Market Place are Available From Sleep...

The Rising Star of Entertainment Marketing Shines Bright

Current KOL-Pharma Relationship Examined in New FirstWord Study...

Drug Patent Expiry Opportunities for API & Generic Companies...

Scientific American
Worm Discovery Illuminates How Our Brains Might Have Evolved

Jawless Vertebrate Had World's Sharpest Teeth

9-Year-Old Boy's Shrinking Brain Disorder Baffles Doctors

"Chum Cam" Helps Catalogue Endangered Sharks

South Africa Wins Panel's Backing to Host Square Kilometer Array Scope

Sports - ESPN Basketball
St. John's Lavin lands coveted recruit Sampson

Bucknell surprises Arizona in first round of NIT

South Florida whips Cal to conclude first round

USC grants F Jackson permission to transfer

Vermont handles Lamar to earn game vs. UNC

Sports News - ESPN
Okla. St. front-loads Gundy's $30.3M contract

Arkansas loses LB Highsmith to pectoral injury

PSU trustees chair: Board considering changes

Former Fiesta Bowl CEO enters 2nd guilty plea

Donation brings Baylor closer to new stadium

Xconomy Life Sciences
Shire Shells Out $100M to Buy Ferrokin Biosciences

Lee Hood's P4 Medicine Institute Gets New Partner, PeaceHealth

Merck Returns to SD, Pouring $90M Into New Schultz-Led Institute

Genocea CEO Chip Clark to Speak at Xconomy's April 4 Biotech Forum

Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)